L

Landos Biopharma, Inc.

29 employees

Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Pharmaceutical
Ulcerative Colitis
Biopharma
Computational Modeling
Inflammatory Bowel Disease
Health Care
Pharmaceuticals
Clinical Trials
Autoimmune Disorders
Therapeutics
Drug Development
Chron's Disease

Date founded

2017

Funding rounds raised

Total raised

$60M

from 6 investors over 6 rounds

L

Landos Biopharma, Inc. raised $60M on August 13, 2019

Investors: RTW Investments, LP, PBM Capital Group, Osage University Partners (OUP), Helicase Venture and Perceptive Advisors

L

Landos Biopharma, Inc. raised $10M on September 21, 2017

Investors: Perceptive Advisors

FAQ